Federal agencies must stop disbursing financial assistance under a new budget directive, threatening funding for providers ...

ITM's lutetium-containing therapy extended progression-free survival versus everolimus in patients with a specific kind of ...

The clearance is a step forward in AstraZeneca and Daiichi Sankyo’s plan to position antibody-drug conjugates like Enhertu ...

Helicore, which is developing a GIP-blocking antibody, is the fourth obesity drug developer to receive funding from Versant ...

Multi-Modal Models: A multi-modal discovery approach was implemented that engineered-in potency against the novel target and engineered-out a specific off-target interaction. The NCE library displayed ...

Sapio Sciences, the science-awareTM lab informatics platform, today announced that Schrödinger, a global leader in computational chemistry, has adopted the Sapio Platform to improve data management, ...

The website changes raise concerns about “the interference of politics with the study and the practice” of science and medicine, one physician said.

The startup says its specially constructed RNAi therapies can get deep into brain tissue, yielding new ways to treat neurological conditions like Huntington’s.

Pharmacies play a key role in improving drug development and patient care, offering insights, clinical trial support and ...

Shares in Veru fell by nearly half following the news, despite positive results in preserving lean muscle mass.

Sage’s board of directors said Biogen’s offer “undervalues” the company, but will explore other strategic alternatives to ...

An experimental drug called amycretin showed signs it could be more potent than Eli Lilly’s rival Zepbound, though analysts ...